Lifecore Biomedical, Inc. (LFCR)

Lifecore Biomedical Ratios and Metrics

Market cap in millions USD. Fiscal year is June - May.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 16, 2025	May 25, 2025	May 26, 2024	May 28, 2023	May 29, 2022	May 30, 2021
Market Capitalization	252	249	172	241	291	351
Market Cap Growth	65.56%	44.93%	-28.69%	-17.27%	-17.12%	12.76%
Enterprise Value	373	419	305	395	424	566
Last Close Price	6.69	6.72	5.62	7.94	9.87	11.97
PE Ratio	-	-	14.29	-	-	-
Forward PE	-	-	25.55	-	-	-
PS Ratio	1.81	1.93	1.34	2.33	2.62	3.48
PB Ratio	185.41	5.25	3.19	6.86	3.31	1.73
P/TBV Ratio	-	-	-	-	4.17	2.45
P/OCF Ratio	-	-	667.99	-	-	21.32
PEG Ratio	-	1.90	1.90	1.90	1.90	1.90
EV/Sales Ratio	2.90	3.25	2.37	3.82	3.81	5.61
EV/EBITDA Ratio	-	-	397.55	-	29.82	69.55
EV/EBIT Ratio	-	-	-	-	-	192.89
Debt / Equity Ratio	2.76	2.76	2.39	3.21	1.71	1.07
Debt / EBITDA Ratio	-	-	101.44	-	9.63	21.03
Asset Turnover	0.52	0.52	0.51	0.39	0.29	0.19
Inventory Turnover	2.45	2.45	2.14	1.96	1.46	0.96
Quick Ratio	1.46	1.46	1.02	1.23	0.22	0.42
Current Ratio	2.84	2.84	2.09	2.39	0.66	1.46
Return on Equity (ROE)	-76.41%	-76.41%	20.97%	-104.52%	-10.65%	-10.80%
Return on Assets (ROA)	-3.04%	-3.04%	-1.77%	-4.67%	-0.55%	0.35%
Return on Capital (ROIC)	-4.16%	-4.16%	-2.72%	-6.39%	-0.65%	0.42%
Return on Capital Employed (ROCE)	-	-	-	-	-	0.70%
Earnings Yield	-17.70%	-15.56%	7.00%	-41.36%	-40.11%	-9.20%
FCF Yield	-5.43%	-5.47%	-10.56%	-16.17%	-18.05%	-2.49%
Buyback Yield / Dilution	5.02%	5.02%	-22.36%	-1.67%	-0.59%	-0.45%

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q